Randal J Kirk - Net Worth and Insider Trading
Randal J Kirk Net Worth
The estimated net worth of Randal J Kirk is at least $1.1 Billion dollars as of 2024-10-10. Randal J Kirk is the 10% Owner of Halozyme Therapeutics Inc and owns about 14,092,771 shares of Halozyme Therapeutics Inc (HALO) stock worth over $714 Million. Randal J Kirk is the 10% Owner of Translate Bio Inc and owns about 7,550,669 shares of Translate Bio Inc (TBIO) stock worth over $282 Million. Randal J Kirk is also the Director, 10% Owner of Precigen Inc and owns about 116,104,879 shares of Precigen Inc (PGEN) stock worth over $99 Million. Besides these, Randal J Kirk also holds Fibrocell Science Inc (FCSC) , AquaBounty Technologies Inc (AQB) , Alaunos Therapeutics Inc (TCRT) , Precipio Inc (PRPO) , Ocugen Inc (OCGN) , Armata Pharmaceuticals Inc (ARMP) , Oragenics Inc (OGEN) , Soligenix Inc (SNGX) , Theriva Biologics Inc (TOVX) . Details can be seen in Randal J Kirk's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Randal J Kirk has not made any transactions after 2024-08-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Randal J Kirk
Randal J Kirk Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Randal J Kirk owns 11 companies in total, including Precigen Inc (PGEN) , AquaBounty Technologies Inc (AQB) , and Fibrocell Science Inc (FCSC) among others .
Click here to see the complete history of Randal J Kirk’s form 4 insider trades.
Insider Ownership Summary of Randal J Kirk
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PGEN | Precigen Inc | 2024-08-09 | director & 10 percent owner & Chief Executive Officer |
| AQB | AquaBounty Technologies Inc | 2021-11-23 | 10 percent owner |
| FCSC | Fibrocell Science Inc | 2019-12-13 | 10 percent owner |
 | | 2019-04-03 | 10 percent owner |
| | 2019-01-15 | 10 percent owner |
| | 2013-10-29 | director |
| | 2018-08-28 | 10 percent owner |
| | 2018-08-28 | 10 percent owner |
| | 2017-05-08 | 10 percent owner |
| | 2016-12-29 | 10 percent owner |
| | 2016-06-30 | 10 percent owner |
Randal J Kirk Latest Holdings Summary
Randal J Kirk currently owns a total of 12 stocks. Among these stocks, Randal J Kirk owns 14,092,771 shares of Halozyme Therapeutics Inc (HALO) as of August 28, 2018, with a value of $714 Million and a weighting of 64.84%. Randal J Kirk owns 7,550,669 shares of Translate Bio Inc (TBIO) as of January 6, 2016, with a value of $282 Million and a weighting of 25.63%. Randal J Kirk also owns 116,104,879 shares of Precigen Inc (PGEN) as of August 9, 2024, with a value of $99 Million and a weighting of 9.02%. The other 9 stocks Fibrocell Science Inc (FCSC) , AquaBounty Technologies Inc (AQB) , Alaunos Therapeutics Inc (TCRT) , Precipio Inc (PRPO) , Ocugen Inc (OCGN) , Armata Pharmaceuticals Inc (ARMP) , Oragenics Inc (OGEN) , Soligenix Inc (SNGX) , Theriva Biologics Inc (TOVX) have a combined weighting of 0.51% among all his current holdings.
Latest Holdings of Randal J Kirk
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HALO | Halozyme Therapeutics Inc | 2018-08-28 | 14,092,771 | 50.65 | 713,798,851 |
| TBIO | Translate Bio Inc | 2016-01-06 | 7,550,669 | 37.36 | 282,092,994 |
| PGEN | Precigen Inc | 2024-08-09 | 116,104,879 | 0.86 | 99,339,334 |
| FCSC | Fibrocell Science Inc | 2017-12-11 | 1,653,483 | 3.00 | 4,960,449 |
| AQB | AquaBounty Technologies Inc | 2021-11-23 | 266,991 | 1.11 | 296,360 |
| TCRT | Alaunos Therapeutics Inc | 2013-10-29 | 118,646 | 2.20 | 261,021 |
| PRPO | Precipio Inc | 2018-08-28 | 4,448 | 6.98 | 31,047 |
| OCGN | Ocugen Inc | 2019-01-15 | 28,207 | 0.95 | 26,766 |
| ARMP | Armata Pharmaceuticals Inc | 2016-12-29 | 10,074 | 2.26 | 22,767 |
| OGEN | Oragenics Inc | 2016-06-30 | 25,803 | 0.38 | 9,883 |
| SNGX | Soligenix Inc | 2017-05-08 | 2,191 | 4.02 | 8,808 |
| TOVX | Theriva Biologics Inc | 2019-04-03 | 911 | 1.65 | 1,503 |
Holding Weightings of Randal J Kirk
Randal J Kirk Form 4 Trading Tracker
According to the SEC Form 4 filings, Randal J Kirk has made a total of 0 transactions in Halozyme Therapeutics Inc (HALO) over the past 5 years. The most-recent trade in Halozyme Therapeutics Inc is the sale of 644,998 shares on August 28, 2018, which brought Randal J Kirk around $12 Million.
According to the SEC Form 4 filings, Randal J Kirk has made a total of 0 transactions in Translate Bio Inc (TBIO) over the past 5 years. The most-recent trade in Translate Bio Inc is the acquisition of 4,474,825 shares on January 6, 2016, which cost Randal J Kirk around $4 Million.
According to the SEC Form 4 filings, Randal J Kirk has made a total of 8 transactions in Precigen Inc (PGEN) over the past 5 years, including 8 buys and 0 sells. The most-recent trade in Precigen Inc is the acquisition of 23,529,411 shares on August 9, 2024, which cost Randal J Kirk around $20 Million.
More details on Randal J Kirk's insider transactions can be found in the Insider Trading History of Randal J Kirk table.Insider Trading History of Randal J Kirk
- 1
Randal J Kirk Trading Performance
GuruFocus tracks the stock performance after each of Randal J Kirk's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Randal J Kirk is 9.37%. GuruFocus also compares Randal J Kirk's trading performance to market benchmark return within the same time period. The performance of stocks bought by Randal J Kirk within 3 months outperforms 40 times out of 71 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Randal J Kirk's insider trading performs compared to the benchmark.
Performance of Randal J Kirk
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.55 | | | | | |
| Relative Return to S&P 500(%) | 13.13 | | | | | |
Randal J Kirk Ownership Network
Randal J Kirk Owned Company Details
What does Precigen Inc do?
Who are the key executives at Precigen Inc?
Randal J Kirk is the director & 10 percent owner & Chief Executive Officer of Precigen Inc. Other key executives at Precigen Inc include SVP & IP Affairs Jeffrey Thomas Perez , director & President and CEO Helen Sabzevari , and Chief Operating Officer Rutul R Shah .
Precigen Inc (PGEN) Insider Trades Summary
Over the past 18 months, Randal J Kirk made 3 insider transaction in Precigen Inc (PGEN) with a net purchase of 24,126,097. Other recent insider transactions involving Precigen Inc (PGEN) include a net purchase of 23,446 shares made by Jeffrey Thomas Perez , a net sale of 227,130 shares made by Helen Sabzevari , and a net sale of 43,556 shares made by Donald P. Lehr .
In summary, during the past 3 months, insiders sold 0 shares of Precigen Inc (PGEN) in total and bought 23,588,234 shares, with a net purchase of 23,588,234 shares. During the past 18 months, 455,706 shares of Precigen Inc (PGEN) were sold and 25,180,265 shares were bought by its insiders, resulting in a net purchase of 24,724,559 shares.
Precigen Inc (PGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Precigen Inc Insider Transactions
Randal J Kirk Mailing Address
Above is the net worth, insider trading, and ownership report for Randal J Kirk. You might contact Randal J Kirk via mailing address: 1881 Grove Avenue, Radford Va 24141.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
